Piotr Mlynarz

Dr. Piotr Mlynarz

Department of Chemistry, Wroclaw University of Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland
orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2023 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
MAMohammad Awashra
Mohammad Awashra
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz
Nowadays, nanomaterials (NMs) are widely present in daily life due to their significant benefits, as demonstrated by their application in many fields such as biomedicine, engineering, food, cosmetics, sensing, and energy. However, the increasing production of NMs multiplies the chances of their release into the surrounding environment, making human exposure to NMs inevitable. Currently, nanotoxicology is a crucial field, which focuses on studying the toxicity of NMs. The toxicity or effects of nanoparticles (NPs) on the environment and humans can be preliminary assessed in vitro using cell models. However, the conventional cytotoxicity assays, such as the MTT assay, have some drawbacks including the possibility of interference with the studied NPs. Therefore, it is necessary to employ more advanced techniques that provide high throughput analysis and avoid interferences. In this case, metabolomics is one of the most powerful bioanalytical strategies to assess the toxicity of different materials. By measuring the metabolic change upon the introduction of a stimulus, this technique can reveal the molecular information of the toxicity induced by NPs. This provides the opportunity to design novel and efficient nanodrugs and minimizes the risks of NPs used in industry and other fields. Initially, this review summarizes the ways that NPs and cells interact and the NP parameters that play a role in this interaction, and then the assessment of these interactions using conventional assays and the challenges encountered are discussed. Subsequently, in the main part, we introduce the recent studies employing metabolomics for the assessment of these interactions in vitro.

1 March 2001 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
AKArtur Krȩżel
Artur Krȩżel
WLWojciech Leśniak
Wojciech Leśniak
MJMałgorzata Jeżowska-Bojczuk
Małgorzata Jeżowska-Bojczuk
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz
JBJustyna Brasuñ
Justyna Brasuñ
Wojciech BalWojciech Bal
Wojciech Bal

7 November 2019 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
KMKarolina Anna Mielko
Karolina Anna Mielko
SJSławomir Jan Jabłoński
Sławomir Jan Jabłoński
JMJustyna Milczewska
Justyna Milczewska
DSDorota Sands
Dorota Sands
MŁMarcin Łukaszewicz
Marcin Łukaszewicz
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz
Pseudomonas aeruginosa is a common, Gram-negative environmental organism. It can be a significant pathogenic factor of severe infections in humans, especially in cystic fibrosis patients. Due to its natural resistance to antibiotics and the ability to form biofilms, infection with this pathogen can cause severe therapeutic problems. In recent years, metabolomic studies of P. aeruginosa have been performed. Therefore, in this review, we discussed recent achievements in the use of metabolomics methods in bacterial identification, differentiation, the interconnection between genome and metabolome, the influence of external factors on the bacterial metabolome and identification of new metabolites produced by P. aeruginosa. All of these studies may provide valuable information about metabolic pathways leading to an understanding of the adaptations of bacterial strains to a host environment, which can lead to new drug development and/or elaboration of new treatment and diagnostics strategies for Pseudomonas. Graphic

1 November 2014 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Stanislaw DejaStanislaw Deja
Stanislaw Deja
IPIrena Porebska
Irena Porebska
AKAneta Kowal
Aneta Kowal
AZAdam Zabek
Adam Zabek
WBWojciech Barg
Wojciech Barg
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz

12 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MOMagdalena Orczyk-Pawilowicz
Magdalena Orczyk-Pawilowicz
EJEwa Jawien
Ewa Jawien
Stanislaw DejaStanislaw Deja
Stanislaw Deja
LHLidia Hirnle
Lidia Hirnle
AZAdam Zabek
Adam Zabek
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz
Metabolic profiles of amniotic fluid and maternal blood are sources of valuable information about fetus development and can be potentially useful in diagnosis of pregnancy disorders. In this study, we applied 1H NMR-based metabolic profiling to track metabolic changes occurring in amniotic fluid (AF) and plasma (PL) of healthy mothers over the course of pregnancy. AF and PL samples were collected in the 2nd (T2) and 3rd (T3) trimester, prolonged pregnancy (PP) until time of delivery (TD). A multivariate data analysis of both biofluids reviled a metabolic switch-like transition between 2nd and 3rd trimester, which was followed by metabolic stabilization throughout the rest of pregnancy probably reflecting the stabilization of fetal maturation and development. The differences were further tested using univariate statistics at α = 0.001. In plasma the progression from T2 to T3 was related to increasing levels of glycerol, choline and ketone bodies (3-hydroxybutyrate and acetoacetate) while pyruvate concentration was significantly decreased. In amniotic fluid, T2 to T3 transition was associated with decreasing levels of glucose, carnitine, amino acids (valine, leucine, isoleucine, alanine, methionine, tyrosine, and phenylalanine) and increasing levels of creatinine, succinate, pyruvate, choline, N,N-dimethylglycine and urocanate. Lactate to pyruvate ratio was decreased in AF and conversely increased in PL. The results of our study, show that metabolomics profiling can be used to better understand physiological changes of the complex interdependencies of the mother, the placenta and the fetus during pregnancy. In the future, these results might be a useful reference point for analysis of complicated pregnancies.

2 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
DSDawid Skrzypczak
Dawid Skrzypczak
ŁJŁukasz Jarzembowski
Łukasz Jarzembowski
Grzegorz IzydorczykGrzegorz Izydorczyk
Grzegorz Izydorczyk
KMKatarzyna Mikula
Katarzyna Mikula
Viktoria HoppeViktoria Hoppe
Viktoria Hoppe
Anna Witek-KrowiakAnna Witek-Krowiak
Anna Witek-Krowiak
Seed coating containing fertilizer nutrients and plant growth biostimulants is an innovative technique for precision agriculture. Nutrient delivery can also be conducted through multilayer seed coating. For this purpose, sodium alginate with NPK, which was selected in a preliminary selection study, crosslinked with divalent ions (Cu(II), Mn(II), Zn(II)) as a source of fertilizer micronutrients, was used to produce seed coating. The seeds were additionally coated with a solution containing amino acids derived from high-protein material. Amino acids can be obtained by alkaline hydrolysis of mealworm larvae (Gly 71.2 ± 0.6 mM, Glu 55.8 ± 1.3 mM, Pro 48.8 ± 1.5 mM, Ser 31.4 ± 1.5 mM). The formulations were applied in different doses per 100 g of seeds: 35 mL, 70 mL, 105 mL, and 140 mL. SEM-EDX surface analysis showed that 70 mL of formulation/100 g of seeds formed a continuity of coatings but did not result in a uniform distribution of components on the surface. Extraction tests proved simultaneous low leaching of nutrients into water (max. 10%), showing a slow release pattern. There occurred high bioavailability of fertilizer nutrients (even up to 100%). Pot tests on cucumbers (Cornichon de Paris) confirmed the new method’s effectiveness, yielding a 50% higher fresh sprout weight and four times greater root length than uncoated seeds. Seed coating with hydrogel has a high potential for commercial application, stimulating the early growth of plants and thus leading to higher crop yields.